Equine antitoxin use and other factors that predict outcome in type A foodborne botulism

Clicks: 363
ID: 261480
1984
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #12 of 25 articles by views in the american journal of medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The use of trivalent equine antitoxin in treating foodborne botulism has not been adequately assessed. One hundred thirty-two cases of type A foodborne botulism reported to the Centers for Disease Control in the period from 1973 to 1980 are reviewed to evaluate the effect of antitoxin therapy and ot …
Reference Key
co1984theequine Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tacket CO;Shandera WX;Mann JM;Hargrett NT;Blake PA;;
Journal the american journal of medicine
Year 1984
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/6720725
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine prognosis female male age factors middle aged Retrospective Studies time factors botulism / therapy* pmid:6720725 doi:10.1016/0002-9343(84)90988-4 c o tacket w x shandera p a blake botulinum antitoxin / administration & dosage* botulism / mortality

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.